Pharmaceutical

Biotech funding optimism rises as 44% predict recovery in 2024

During 2023, funding decreased by 43.2% compared to 2022 and by 52.3% compared to 2021, attributed to macroeconomic pressures.

Mar 1, 2024 - 18:00
Biotech funding optimism rises as 44% predict recovery in 2024
During 2023, funding decreased by 43.2% compared to 2022 and by 52.3% compared to 2021, attributed to macroeconomic pressures.
Read the original article

Tags:

Previous Article

Panama updates their medicine regulatory system

Next Article

Green granulation: Tracking energy efficiency in pharmaceutical granulation

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Delay of eye drop recall highlights FDA’s impotence on the issue

STAT+: Delay of eye drop recall highlights FDA’s impote...

Nov 21, 2023

STAT+: ADA says all diabetes patients should be screened for nonalcoholic fatty liver disease

STAT+: ADA says all diabetes patients should be screene...

Jun 26, 2023

Debio-4127 by Debiopharm International for Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET): Likelihood of Approval

Debio-4127 by Debiopharm International for Neuroendocri...

Nov 4, 2023